Dyne therapeutics market cap
WebMarket Cap 781.90M. Shares Outstanding 52.13M. EPS (TTM) -3.2357. P/E (TTM) -Fwd Dividend (% Yield) -Ex-Dividend Date - ... Dyne Therapeutics Inc. is a muscle disease company ... WebDyne Therapeutics Inc stocks price quote with latest real-time prices, charts, financials, latest news, technical analysis and opinions. ... Market Cap: capitalization or market value of a stock is simply the market value of all outstanding shares. It is computed by multiplying the market price by the number of outstanding shares.
Dyne therapeutics market cap
Did you know?
WebDyne Therapeutics, Inc., a muscle disease company, operates as a biotechnology company that focuses on advancing therapeutics for genetically driven muscle diseases in the United States. It develops various programs for myotonic dystrophy type 1, duchenne muscular dystrophy, and facioscapulohumeral dystrophy, as well as rare skeletal muscle ... WebFind real-time DYN - Dyne Therapeutics Inc stock quotes, company profile, news and forecasts from CNN Business. ... Market cap: $528.5M: Data as of 3:59pm ET, 04/10/2024. Growth & Valuation.
WebApr 7, 2024 · See the latest Dyne Therapeutics Inc Ordinary Shares stock price (NASDAQ:DYN), related news, valuation, dividends and more to help you make your … Web19 hours ago · Find the latest Price To Free Cash Flow for Dyne Therapeutics (DYN) ... Large-Cap Trader; ... 03/23/23-11:00AM EST Market News Video Dyne Therapeutics Receives FDA Orphan Drug and Rare Pediatric ...
WebDyne Therapeutics to Present at Upcoming Investor Conferences. WALTHAM, Mass., March 07, 2024 (GLOBE NEWSWIRE) -- Dyne Therapeutics, Inc. (Nasdaq: DYN), a clinical-stage muscle disease company focused on advancing innovative life-transforming therapeutics for people living with genetically driven diseases, today announced that … WebApr 6, 2024 · 91,5%. More Financials. Company. Dyne Therapeutics Inc. is a muscle disease company. The Company is focused on advancing therapeutics for patients with genetically driven diseases. It is utilizing its FORCE platform to overcome the limitations of muscle tissue delivery and oligonucleotide therapeutics for muscle diseases.
WebMar 20, 2024 · Dyne Therapeutics is a clinical-stage muscle disease company focused on advancing innovative life-transforming therapeutics for people living with …
WebMar 29, 2024 · Get a real-time Dyne Therapeutics, Inc. (DYN) stock price quote with breaking news, financials, statistics, charts and more. ... Market Cap: 628.17M: Revenue (ttm) n/a: Net Income (ttm)-168.10M: Shares Out 56.34M: EPS (ttm)-3.23: PE Ratio ... Chardan Initiates Coverage On These 'Intriguing Small-Cap Stories" Chardan Research … in what year did the wto replace gattWebApr 11, 2024 · Dyne Therapeutics, Inc., a muscle disease company, operates as a biotechnology company that focuses on advancing therapeutics for genetically driven … in what year did the volcano on thera eruptWebView the latest Dyne Therapeutics Inc. (DYN) stock price, news, historical charts, analyst ratings and financial information from WSJ. in what year did world war i beginWebDyne Therapeutics (DYN) has a Smart Score of 7 based on an analysis of 8 unique data sets, including Analyst Recommendations, Crowd Wisdom, and Hedge Fund Activity. ... Market Cap. $495.76M. Enterprise Value $263.49M. Total Cash (Recent Filing) $256.01M. Total Debt (Recent Filing) $30.48M. Price to Earnings (P/E)-2.7. Beta 0.93. Next … onmousewheel 事件WebDyne Therapeutics, Inc. Analyst Report: Xcel Energy Inc. Xcel Energy manages utilities serving 3.7 million electric customers and 2.1 million natural gas customers in eight states. Discover historical prices for DYN stock on Yahoo Finance. View daily, weekly or … Get the detailed quarterly/annual income statement for Dyne Therapeutics, Inc. … View the basic DYN option chain and compare options of Dyne Therapeutics, … Find out the direct holders, institutional holders and mutual fund holders for … Dyne Therapeutics, Inc. 1560 Trapelo Road Waltham, MA 02451 United States 781 … See Dyne Therapeutics, Inc. (DYN) stock analyst estimates, including earnings … Find out all the key statistics for Dyne Therapeutics, Inc. (DYN), including … Dyne Therapeutics to Present at Upcoming Investor Conferences. WALTHAM, … See Dyne Therapeutics, Inc. (DYN) Environment, Social and Governance … Find the latest Dyne Therapeutics, Inc. (DYN) stock quote, history, news and … on movies channel nowWebJan 18, 2024 · Dyne Therapeutics had its IPO a year ago. The clinical-stage biotech has $407.5 million in cash but no revenue. The company specializes in treating serious … in what year did the soviet union disbandWebApr 11, 2024 · The firm has a market capitalization of $496.90 million, a P/E ratio of -2.72 and a beta of 0.24. Dyne Therapeutics has a 12 month low of $4.30 and a 12 month high of $15.63. onmove agencja